RESUMO

OBJECTIVES: To assess perimenopausal users of 52 mg levonorgestrel intrauterine devices (LNG-IUD) regarding the IUD impact after menopause. MATERIAL AND METHODS: a cross-sectional study with users aged 40 and 49 years old, without cognitive impairment that answered a questionnaire regarding worries and benefits after the menopause due to LNG-IUD use. RESULTS: Almost half of 221 users (52.9%) have concerns that LNG-IUD use could influence aspects after menopause, 111 (50.3%) that the post-menopause symptoms get worse and 92 (41.6%) that interfere with recognition of menopausal symptoms. CONCLUSION: Half of perimenopausal LNG-IUD users expressed concerns about how device use could affect post-menopause symptoms.

---

The 52 mg hormonal-IUD who were at menopausal transition reported worries that the use of the IUD can affect menopausal symptoms. It is important that health professionals can routinely guide these women.

Assuntos

Anticoncepcionais Femininos , Dispositivos Intrauterinos de Cobre , Dispositivos Intrauterinos Medicados , Dispositivos Intrauterinos , Feminino , Humanos , Adulto , Pessoa de Meia-Idade , Levanogestrel , Pós-Menopausa , Estudos Transversais , Menopausa , Dispositivos Intrauterinos Medicados/efeitos adversos

RESUMO

Physical activity is broadly recognized for promoting weight reduction and bestowing numerous health benefits. Nonetheless, robust evidence concerning the impact of physical activity on postmenopausal women, undergoing physiological shifts, remains scant. This study aimed to elucidate the relationship between physical activity and body composition among postmenopausal women. Employing a cross-sectional and retrospective design, 702 women were examined. Data on physical activity and body composition were amassed through anthropometric assessments and Dual-Energy X-ray Absorptiometry (DEXA). A significant proportion of women exhibited anthropometric alterations indicative of overweight/obesity, alongside elevated values in Waist Circumference (WC), Waist-to-Hip Ratio, Waist-to-Height, and bone mass, signifying a heightened risk for disease onset. While a majority engaged in some form of physical activity, this did not yield notable reductions in the assessed metrics. Noteworthy changes were only discerned in BMI and bone mass among pre-menopausal women; whereas among postmenopausal women, in addition to disparities in bone mass, those inactive were 1.18 times more prone to a very high disease risk, as gauged by WC.

RESUMO

The menopausal transition stage brings physiological changes associated with the development of metabolic syndrome (MetS), which can affect bone mineral density (BMD), and may be more evident in the postmenopausal stage. The aim of this study was assessing the association between low BMD and MetS and its components among reproductive/menopausal transition and postmenopausal women in the northeast region of Mexico. A descriptive cross-sectional study was carried out (2015-2016) in 40-60-year-old women (n = 376) who were residents in the metropolitan area of Monterrey, in Nuevo Leon State, Mexico. Anthropometric measurements, blood pressure, a dual-energy X-ray absorptiometry (DXA) evaluation of BMD of two anatomical sites (lumbar spine and dual femur), and a biochemical analysis were obtained. The prevalence of MetS was 57.2%. In participants without MetS, the prevalence of osteopenia was 27.3% in the lumbar spine and 18.6% in the dual femur, while in participants with MetS, the prevalence of osteopenia was 35.8% in the lumbar spine and 14.4% in the dual femur. Osteoporosis in participants without MetS was present in 6.8% in the lumbar spine and in 1.8% in the dual femur, while in women with MetS, its prevalence was 4.7% in the lumbar spine and 0.5% in the dual femur. An association between low BMD at the lumbar spine and dual femur and components of MetS diseases was identified in Mexican women as follows: waist circumference ≥ 88 cm showed an increase risk for low BMD at femoral site in both reproductive/menopausal transition (OR 7.638; 95% CI: 1.607-36.298; p = 0.011) and postmenopausal women (OR 2.600; 95% CI: 1.023-6.609; p = 0.045); HDL < 50 mg/dL was associated with low BMD in both the femur (OR 3.639; 95% CI: 1.039-12.743; p = 0.043) and lumbar spine (OR 2.654; 95% CI: 1.092-6.447; p = 0.031); hypertension in postmenopausal women increased the risk for low BMD in the femur (OR 2.634; 95% CI: 1.150-6.035; p = 0.022). In conclusion, we found that components of the MetS were associated with low BMD, thus indicating that MetS increases the risk for developing osteopenia or osteoporosis. Furthermore, age was found to be an independent risk factor for low BMD.

RESUMO

Las mujeres en climaterio o transición menopáusica frecuentemente reportan quejas de memoria. El Estudio Esmeralda busca relacionar los Síntomas del Climaterio (SC) femenino en sus diferentes etapas: premenopausia (etapa -2, temprana de la transición menopáusica), perimenopausia (etapas -1 y +1ª, tardía de la transición menopáusica y temprana de postmenopausia) y postmenopausia (etapas +1b, +1c y +2, temprana de postmenopausia con tardía de postmenopausia), con posible deterioro del funcionamiento intelectual, que pudiera llevar a sospechar de Trastorno Neurocognitivo leve (TNCl). La muestra final quedó conformada por 100 mujeres con alto nivel de escolaridad entre 40 y 60 años de edad. Se realizó un estudio no experimental transversal con muestreo no probabilístico, utilizando la Evaluación Cognitiva Montreal (MoCA). Se obtuvieron resultados normativos en 43.27% de la muestra y Deterioro Cognitivo Leve (DCL) en 56.73%, encontrando diferencia de medias significativas al nivel 0.05 en las tres etapas de climaterio, resultando la mayor incidencia en perimenopausia, etapa de mayor disminución de estrógenos. Se concluye que cambios en la función intelectual, pueden estar asociados a variación hormonal. Se puede determinar TNCl en forma temprana, en busca de una atención primaria y puesta en marcha de reactivación de funciones intelectuales.

---

Women in the climacteric stage or menopausal transition, frequently report complaint in memory. Emerald Study search relate feminine climacteric syndrome in their different steps: premenopause (stage -2 early menopausal transition), perimenopause (stages -1 and +1a late menopausal transition and early postmenopause) and postmenopause (stages +1b, +1 c and +2 early postmenopause with late postmenopause), with a possible mild cognitive impairment, that carry on suspect of Mild Neurocognitve Disorder (mNCD). The final sample were 100 women with high schooling level between 40 and 60 years old. A nonexperimental, non-probability cross-sectional study was conducted through the Montreal Cognitive Assessment (MoCA). Normative results were obtained in 43.27% and mNCD in 56.73%, finding difference of significant means at the 0.05 level in the three stages of climacteric, resulting in the highest incidence in perimenopause, stage of greatest decrease in estrogen. It is concluded that changes in intellectual function may be associated with hormonal variation. mNCD can be determined early, in search of primary care and start-up of reactivation of intellectual functions.

Assuntos

Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Climatério , Disfunção Cognitiva/diagnóstico , Testes Neuropsicológicos , Menopausa

RESUMO

RESUMEN OBJETIVO: Conocer los síntomas en la Transición Menopáusica, mediante el autoinforme de la mujer, clasificado en tres grupos: 1er. Temprana de la Transición Menopáusica (etapa −2), 2°. Tardía de la Transición Menopáusica y Temprana de Postmenopausia (etapas −1 y +1a) y 3er. grupo Temprana de Postmenopausia con Tardía de Postmenopausia (etapas +1b, +1c y +2), analizando síntomas psicológicos. MATERIAL Y MÉTODO: Estudio no experimental transversal muestreo no probabilístico. Participantes 116 mujeres en un rango de edad entre 40 y 60 años con alto nivel de escolaridad, mediante la Escala de Clasificación en la Menopausia MRS, el Inventario de Ansiedad y Depresión de Beck. RESULTADOS: La muestra quedó conformada por un total de 100 mujeres con al menos un síntoma, con alto nivel de escolaridad y en el rango de edad de 40 a 60 años, agrupadas por etapa de Transición Menopáusica: 1er. grupo 36 mujeres, 2°. grupo 16 y 3er. grupo con 48 personas. Los síntomas psicológicos medidos con MRS son los más frecuentes en 41.60%; reportan queja subjetiva de pérdida de memoria 57% de las mujeres. Alfa Cronbach de .74 en MRS. CONCLUSIONES: Los síntomas psicológicos están presentes como un continuo a lo largo de la Transición Menopáusica, posiblemente debidos a la disminución de concentración de estrógenos, lo que conlleva en algunos casos al diagnóstico de Trastorno Neurocognitivo Leve.

---

ABSTRACT OBJECTIVE: To know the symptoms in the Menopausal Transition, through the self-report of the women, classified into three groups: 1st. Early Menopausal Transition (stage −2), 2nd. Late Menopausal Transition and Early Postmenopause (stages −1 and +1a) and 3rd. group Early Postmenopause with Late Postmenopause (stages +1b, +1 c and +2), analyzing psycological symptoms. MATERIAL & METHOD: Non-experimental transversal study, non-probabilistic sampling. The participants were 116 women between 40 and 60 years old with high schooling level, through The Menopause Rating Scale MRS, Beck Anxiety Inventory and Depression Inventory. RESULTS: The final sample consisted of 100 women with at least one symptom, with a high schooling level in the range of 40 to 60 years, grouped by Menopausal Transition stage: 1st. 36 women, 2nd. Group 16 and 3rd. group with 48. The psycological symptoms measured with MRS were the most frequently in 41.60%; report subjective complaint of memory loss 57% of women. Alfa Cronbach of .74 in MRS. CONCLUSION: Psychological symptoms are present as a continuum throughout the Menopausal Transition, possibly due to the decreased concentration of estrogen, which in some cases leads the diagnosis of Mild Neurocognitive Disorder.

Assuntos

Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Psicometria/métodos , Menopausa/psicologia , Disfunção Cognitiva , Qualidade de Vida , Estudos Transversais , Inquéritos e Questionários

RESUMO

OBJECTIVE: To determine the frequency and severity of menopausal symptoms and associated factors in middle-aged Brazilian women. METHODS: A cross-sectional study was carried out involving 1415 women aged 35-65 years attended at the Outpatient unit of the Clinicas Hospital of Rio Branco, Acre state, Brazil. The Menopause Rating Scale (MRS) was used to assess the severity of menopause symptoms. The Stata 10 statistical package was used for all data analysis whereas Pearson's x(2) nonparametric association test was used for bivariate analysis, adopting a level of statistical significance of 5%. On the multivariate analysis, independent variables positively associated with the dependent model were retained in the final model (p<0.005). RESULTS: Overall, 54.1% of participants were premenopausal, 10.1% perimenopausal, and 35.8% postmenopausal. Irritability was the most frequent symptom (78.3%), followed by joint and muscular discomfort (74.8%), and anxiety (72.7%). Mean total MRS score was 15.6+8.8 (median 15). After adjusting for confounding factors, the logistic regression analysis found low educational level (OR:1.53; [95% CI:1.21-1.95]; p<0.001); self-perceived poor/very poor health (OR:4.48; [95% CI: 3.53-5.69]; p<0.001), and menopausal transition phase (OR:1.73; [95% CI:1.18-2.53]; p=0.005) to be statistically significantly associated with more severe menopausal symptoms. CONCLUSION: Among Brazilian women, atypical symptoms of the menopause were the most frequently reported. Severe menopausal symptoms were more likely in women with low educational level, self-perceived poor health and at the menopausal transition phase.

Assuntos

Ansiedade/etiologia , Escolaridade , Nível de Saúde , Humor Irritável , Menopausa , Dor Musculoesquelética/etiologia , Adulto , Ansiedade/epidemiologia , Brasil/epidemiologia , Estudos Transversais , Feminino , Humanos , Modelos Logísticos , Pessoa de Meia-Idade , Análise Multivariada , Dor Musculoesquelética/epidemiologia , Razão de Chances , Percepção , Perimenopausa , Pós-Menopausa , Pré-Menopausa , Prevalência , Índice de Gravidade de Doença

RESUMO

A transição menopausal pode representar um momento crítico para a sexualidade da mulher, já que nessa fase ocorre deficiência de hormônios esteroides sexuais, resultante da insuficiência ovariana, secundária à diminuição dos folículos primordiais. O estudo teve como objetivo avaliar a relação da força muscular do assoalho pélvico com a satisfação sexual de mulheres na transição menopausal. Foi avaliado o desempenho sexual por meio do Quociente Sexual - Versão Feminina (QS-F) e a força muscular do assoalho pélvico pela avaliação funcional do assoalho pélvico (AFA) e perineômetro de quatro mulheres na transição menopausal, com média de idade 48,5 ± 5,5 anos. Observou-se que as duas mulheres com menor força muscular do assoalho pélvico (AFA 2 e 7-8 cmH2O) foram as que obtiveram a classificação de regular a bom do desempenho sexual (78 e 80 pontos, respectivamente) e as com maior força muscular (AFA 4 e 3) foram classificadas com desempenho sexual bom a excelente (84 e 90 pontos, respectivamente). Embora seja necessária uma amostra maior para a comprovação desta conexão, os resultados mostraram que há relação entre a força muscular do assoalho pélvico e a satisfação sexual em mulheres na transição menopausal, ou seja, quanto maior a força muscular, melhor o desempenho sexual...

Assuntos

Humanos , Feminino , Pessoa de Meia-Idade , Diafragma da Pelve , Força Muscular , Menopausa

RESUMO

A Incontinência Urinária (IU) é a perda involuntária de urina e, entre os fatores envolvidos no seu determinismo, a obesidade assume particular importância. Entretanto, ainda não está claro se o fator determinante é a gordura abdominal, mensurada pela medida da circunferência abdominal (CA), ou o excesso de gordura corpórea, avaliado pelo Índice de Massa Corpórea (IMC). Objetivos: Estimar a prevalência de IU em mulheres na transição menopausal e após a menopausa; verificar se há associação com o IMC e com a medida da CA em seu determinismo além de avaliar a qualidade de vida nas mulheres incontinentes estudadas. Métodos: Em estudo transversal, foram obtidos dados secundários a partir do banco de dados do Projeto de Saúde de Pindamonhangaba, pertencentes ao Programa de Saúde da Família, do referido Município. A população do estudo foram mulheres nos estágios da transição menopausal e pós menopausa, com idade entre 35 e 65 anos. Todas foram submetidas a uma entrevista sistematizada, que incluiu questões sobre perfil sociodemográfico, história ginecológica e obstétrica, incontinência urinária, morbidade e avaliações antropométricas, como altura, peso e medida da CA e coleta de sangue. Resultados: A prevalência da IU foi de 17,0 por cento e entre os fatores significativos associados ao seu determinismo incluíram-se episiotomia, religião evangélica, depressão, tabagismo atual, síndrome metabólica e medida da CA acima de 88 cm. Com relação à qualidade de vida das incontinentes, 16,1 por cento das mulheres relataram que a incontinência tem impacto na qualidade de vida e 3,2 por cento classificaram esse impacto como grave. Conclusão: A prevalência da IU foi menor em comparação a outros estudos, porém, constatou-se piora da qualidade de vida das incontinentes; com relação à obesidade, observou-se que a medida da CA maior que 88 cm se associou significativamente com a IU, o mesmo não ocorrendo com o IMC.

---

Urinary Incontinence (UI) is the involuntary loss of urine and among the factors involved in its determinism, obesity takes particular importance. However, it is unclear whether the determinant factor is the abdominal fat measured by measuring the Abdominal Circumference (AC) and or the excess of body fat assessed by the Body Mass Index (BMI). Objectives: To estimate the prevalence of UI in women in menopausal transition and after menopause; check for an association between the BMI with the AC measure in its determinism and evaluate the quality of life in studied incontinent women. Methods: In cross-sectional study were obtained secondary data from the database of the Pindamonhangaba's Health Project, belonging to the Family Health Program of that municipality. The study population were women in transition and postmenopause stages, aged between 35 and 65. All were subjected to a systematic interview that included questions about Sociodemographic profile, obstetrical and gynecological history, urinary incontinence, morbidity and anthropometric measurements such as height, weight, AC measurement and blood collection. Results: The prevalence of U was 17.0 per cent and among the significant factors associated with its determinism is included episiotomy, evangelical religion, depression, current tabagism, metabolic syndrome and CA measurement above 88 cm. Regarding the quality of life, 16.1 per cent of incontinent women reported having an impact on quality of life and 3.2 per cent classified it as severe. Conclusion: The prevalence of UI was lower compared to other studies, however, it was found a worsening in incontinents' quality of life; in relation to obesity, it was observed that the measurement of AC > 88 cm was significativelly...

Assuntos

Feminino , Adulto , Pessoa de Meia-Idade , Humanos , Climatério , Incontinência Urinária/epidemiologia , Obesidade , Pós-Menopausa , Qualidade de Vida , Saúde da Mulher , Antropometria , Composição Corporal

RESUMO

OBJETIVO: realizar revisão sistemática de estudos de prevalência dos sintomas depressivos na perimenopausa. MÉTODO: A pesquisa foi efetuada a partir das bases de dados MEDLINE e EMBASE. Foram incluídos estudos transversais originais com populações adultas (idade de 40 a 55 anos), no período de 1996 a 2006, que estimaram a prevalência de sintomas depressivos na perimenopausa nos idiomas: inglês, francês, espanhol e português. A seleção dos estudos pela estratégia de busca foi feita de forma independente por dois avaliadores. Foram incluídos os estudos que preencheram os seguintes critérios metodológicos: características epidemiológicas, definições de perimenopausa, instrumentos válidos utilizados para sintomas depressivos. RESULTADOS: Após a avaliação de 1.345 artigos, restaram apenas cinco que caracterizaram uma população de 11.020 mulheres com idades entre 40 e 60 anos. Constatamos que a prevalência de sintomas depressivos na perimenopausa variou entre 19 por cento e 73 por cento. CONCLUSÃO: A presente revisão sistemática mostrou expressiva variação na prevalência de sintomas depressivos na perimenopausa; ademais, não foi possível caracterizar se a sintomatologia depressiva na perimenopausa decorreu exclusivamente de flutuações hormonais observadas neste estágio da vida ou de antecedentes prévios de depressão.(AU)

---

OBJECTIVE: a systematic review of studies that investigated the prevalence of depressive symptoms in perimenopausal women. Method: The research was conducted in MEDLINE and EMBASE databases. Original transversal studies in from 1996 to 2006 with adult populations were enclosed (age between 40 and 55 years old) and demonstrated prevalence of depressive symptoms in the perimenopause in the following languages: English, French and Portuguese. The studies selection was conducted by two independent evaluators. The inclusion criteria were studies which fulfilled the following methodological criteria: epidemiological characteristics, perimenopause definitions and valid instruments to evaluate depressive symptoms. RESULTS: After the evaluation of 1.345 articles, 1099 were excluded since they did not satisfy the criteria of inclusion, remaining only five articles with a population of 11.020 women with ages between 40 and 60 years and, therefore, part of the studied sample enclosed in perimenopause. This study revealed a prevalence of depressive symptoms in perimenopause, which varied between 19 percent and 73 percent. CONCLUSION: The present systematic review showed substantial variation in the prevalence of depressive symptoms in perimenopause; in addition, it was not possible to characterize if the depressive symptoms in perimenopause were exclusively due to hormonal fluctuations in this stage life or if related to previous preceding moments of depression.(AU)